Francesco Bavo

Potent Antiglioblastoma Agents by Hybridizing the Onium-Alkyloxy-Stilbene Based Structures of an α7-nAChR, α9-nAChR Antagonist and of a Pro-Oxidant Mitocan

Francesco Bavo, Susanna Pucci, Francesca Fasoli et al. · Journal of Medicinal Chemistry · 2018 · 26 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Five-Membered <i>N</i>-Heterocyclic Scaffolds as Novel Amino Bioisosteres at γ-Aminobutyric Acid (GABA) Type A Receptors and GABA Transporters

Alessandro Giraudo, Jacob Krall, Francesco Bavo et al. · Journal of Medicinal Chemistry · 2019 · 24 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Molecular Hybridization of Potent and Selective γ-Hydroxybutyric Acid (GHB) Ligands: Design, Synthesis, Binding Studies, and Molecular Modeling of Novel 3-Hydroxycyclopent-1-enecarboxylic Acid (HOCPCA) and<i>trans</i>-γ-Hydroxycrotonic Acid (T-HCA) Analogs

Jacob Krall, Claus Jensen, Francesco Bavo et al. · Journal of Medicinal Chemistry · 2017 · 23 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of 2-(Imidazo[1,2- <i>b</i> ]pyridazin-2-yl)acetic Acid as a New Class of Ligands Selective for the γ-Hydroxybutyric Acid (GHB) High-Affinity Binding Sites

Jacob Krall, Francesco Bavo, Christina Birkedahl Falk‐Petersen et al. · Journal of Medicinal Chemistry · 2019 · 19 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

From pyrrolidinyl-benzodioxane to pyrrolidinyl-pyridodioxanes, or from unselective antagonism to selective partial agonism at α4β2 nicotinic acetylcholine receptor

Cristiano Bolchi, Francesco Bavo, Cecilia Gotti et al. · European Journal of Medicinal Chemistry · 2016 · 17 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13